Alteration of P-gp Expression after Intestinal Ischemia-reperfusion Following 16-h Fasting in Rats

被引:7
作者
Ogura, Jiro [1 ]
Fujikawa, Asuka [1 ]
Maruyama, Hajime [1 ]
Kobayashi, Masaki [1 ]
Itagaki, Shirou [1 ]
Iseki, Ken [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci, Lab Clin Pharmaceut & Therapeut,Kita Ku, Sapporo, Hokkaido 0600812, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2011年 / 131卷 / 03期
关键词
intestinal ischemia-reperfusion; fasting; P-glycoprotein; MULTIDRUG-RESISTANCE; ISCHEMIA/REPERFUSION INJURY; GLYCOPROTEIN EXPRESSION; INFLAMMATORY CYTOKINES; PROTEIN EXPRESSION; LIVER; ACID; GENE; PHOSPHATIDYLCHOLINE; SUPPLEMENTATION;
D O I
10.1248/yakushi.131.453
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Alteration of P-glycoprotein (P-gp) expression influences the pharmacokinetics of P-gp substrates after intestinal ischemia-reperfusion (I/R). Fasting before intestinal I/R affects intestinal I/R injury. However, the effect of fasting on the alteration of P-gp expression after intestinal I/R has not been clarified. We previously reported that P-gp expression was altered after intestinal I/R following feeding. In the present study, we investigated the expression of P-gp after intestinal I/R following 16-h fasting. The mdr1a levels were decreased at 6 h in the jejunum, at I h in the ileum, at 6 and 24 h in the liver and at 6 h in the kidney. The mdr1b levels were decreased at 6 h in the ileum and at 1 and 6 h in the kidney. The mdr1b level in the liver was increased at 1 and 6 h. The expression of P-gp was decreased at 6 h in the jejunum, at 1, 6 and 24 h in the ileum, and at 6 h in the kidney. These alterations were different to those after intestinal I/R following feeding. In particular, the decrease in P-gp expression in the 16-h fasting I/R rats occurred at an early time during reperfusion compared with that in the feeding I/R rats. In conclusion, feeding condition affects the alteration of P-gp expression after intestinal I/R. Therefore, it is important to understand the patient's feeding condition for safe drug therapy.
引用
收藏
页码:453 / 462
页数:10
相关论文
共 41 条
[1]
Enteral feeding decreases gut apoptosis, permeability, and lung inflammation during murine endotoxemia [J].
Alscher, KT ;
Phang, PT ;
McDonald, TE ;
Walley, KR .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (02) :G569-G576
[2]
Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine [J].
Berggren, Sofia ;
Gall, Christine ;
Wollnitz, Nadine ;
Ekelund, Mats ;
Karlbom, Urban ;
Hoogstraate, Janet ;
Schrenk, Dieter ;
Lennernas, Hans .
MOLECULAR PHARMACEUTICS, 2007, 4 (02) :252-257
[3]
Ischemia/reperfusion injury of rat small intestine: The effect of allopurinol dosage [J].
Ciz, M ;
Cizova, H ;
Lojek, A ;
Kubala, L ;
Papezikova, I .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (05) :2871-2873
[4]
Deitch E A, 1996, New Horiz, V4, P289
[5]
PROPERTIES OF BRUSH-BORDER VESICLES ISOLATED FROM RAT-KIDNEY CORTEX BY CALCIUM PRECIPITATION [J].
EVERS, C ;
HAASE, W ;
MURER, H ;
KINNE, R .
MEMBRANE BIOCHEMISTRY, 1978, 1 (3-4) :203-219
[6]
Fernandez C, 2004, J PHARM PHARM SCI, V7, P359
[7]
Extrahepatic cholestasis downregulates Oatp1 by TNF-α signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver [J].
Geier, Andreas ;
Dietrich, Christoph G. ;
Trauner, Michael ;
Gartung, Carsten .
LIVER INTERNATIONAL, 2007, 27 (08) :1056-1065
[8]
Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines [J].
Gomez-Martinez, Angeles ;
Garcia-Morales, Pilar ;
Carrato, Alfredo ;
Castro-Galache, Maria D. ;
Soto, Jose L. ;
Carrasco-Garcia, Estefania ;
Garcia-Bautista, Miriam ;
Guaraz, Patricia ;
Ferragut, Jose A. ;
Saceda, Miguel .
MOLECULAR CANCER RESEARCH, 2007, 5 (06) :641-653
[9]
Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice [J].
Hartmann, G ;
Kim, H ;
Piquette-Miller, M .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (02) :189-199
[10]
Horie Y, 2001, Pathophysiology, V8, P11, DOI 10.1016/S0928-4680(01)00063-3